CLSA Announces Winner of “Giants of Science” Life Sciences Grant Competition
California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, and California Life Sciences Institute (CLSI) today announced that Los Altos High School has been selected as the winner of the Giants of Science competition, a program that awards $20,000 to a deserving Bay Area high school to support STEM education and the next generation of life sciences leaders. Moving into its 3rd year, Giants of Science is hosted by KNBR, CLSA and CLSI – the non-profit partner of CLSA which supports workforce development, STEM education and entrepreneurship.
CLSA in STAT: Life sciences industry rallies behind Calif. bill to prevent a nightmare scenario for clinical research
CLSA recently spoke with STAT News regarding SB 1121, critical legislation on Gov. Brown’s desk that will preserve California patient access to clinical trials and allow innovative research to continue.
CLSA Names Winners of 15th Annual Pantheon DiNA™ Awards, Honoring Innovation in Life Sciences
Today, CLSA announced the recipients of the 2018 Pantheon DiNA™ Awards. This prestigious and long-running awards program, now in its 15th year, brings together nearly 1,000 industry pioneers to recognize the achievements of those dedicated to advancing California’s life sciences community.
With Sacramento Legislation Session Over, CLSA Optimistic on Fate of Key Bills
Two major bills of interest to CLSA have been presented to Governor Brown for his signing or veto: include SB 212 (Jackson) and SB 1121 (Dodd). A third key bill of interest to CLSA, AB 2167 (Chau), died in the Senate during the final week of the legislative session.
State Nears Final Rules on SB 17 Implementation
On Aug. 29, California’s Office of Statewide Health Planning and Development (OSHPD) held a public hearing regarding proposed regulations to implement Senate Bill 17, which was signed into law last year.
CLSA Urges Governor Jerry Brown to Sign Legislation to Protect Clinical Trials and Patient Access in California
California Life Sciences Association (CLSA) today urged Governor Jerry Brown to sign Senate Bill 1121, legislation that helps protect clinical trials conducted in California, which are the lifeblood of new and innovative medicines to treat patients in need. SB 1121 was approved by the California Legislature earlier this year and awaits action by Governor Brown, who has until Sept. 30 to sign or veto the legislation.
CLSA Sponsors 6th Annual Rally for Medical Research on Capitol Hill
CLSA was a proud sponsor and participant of the 6th Annual Rally for Medical Research & National Day of Action on Sept. 13-14, 2018, an annual event that brings together more than 300 organizations to call on our nation’s policymakers to make funding for National Institutes of Health (NIH) a national priority.
CLSA Co-Hosts Congressional Briefing on Importance of Intellectual Property in Advancing Global Health
On Sept. 11, CLSA co-hosted a multi-state life sciences association Congressional briefing on the patent system and how it works toward encouraging innovation in the development of life saving technologies.
CLSA in the San Diego Business Journal: Making Digital Health Happen
Did you miss CLSA’s Evening With Thought Leaders event in August? Check out this article from the San Diego Business Journal to learn more about the digital health symposium.
CLSA in the San Francisco Business Times: Move over, Massachusetts: California takes top spot for biotech R&D jobs
CLSA President & CEO Sara Radcliffe was recently quoted in the San Francisco Business Times commenting on a new report that shows California’s life sciences sector has the most biotech R&D jobs in the nation.